Research Library / Article Summary

Recovery of anterior prefrontal cortex inhibitory control after 15 weeks of inpatient treatment in heroin use disorder

Plain-English AddictionTube research summary with source link, DOI, key finding, and recovery relevance.

Nature Mental Health • 29 Apr 2024 • Research

opioidbrain sciencegeneticstreatment

Research focus

This article may help explain addiction science through research on opioid, brain science, genetics, treatment. The source abstract begins by describing: “Heroin addiction imposes a devastating toll on society.”

Key finding: The authors examined the effect of psychosocial therapy, in addition to medication for heroin dependence, on inhibitory control brain activity and behavioral performance in individuals with heroin use disorder.

Why this may help: This may help explain why addiction can involve brain, behavior, mental health, craving, relapse, or treatment factors rather than simple willpower alone. It should be read as research information, not personal medical advice.

Article details

Authors: Ahmet O. Ceceli, Yuefeng Huang, Rita Z. Goldstein

DOI: 10.1038/s44220-024-00230-4

Open access: Not marked open access

Open original source article

Related article summaries

Ethanol Blocks Long-Term Potentiation of GABAergic Synapses in the Ventral Tegmental Area Involving μ-Opioid Receptors

This article may help explain addiction science through research on opioid, alcohol, dopamine, brain science. The source abstract begins by describing: “It is well documented that ethanol exposure alters GABA (γ-aminobutyric acid)-releasing synapses, and ethanol addiction is associated with endogenous opioid system.”

Key finding: These neuroadaptations to ethanol might contribute to early stage of addiction.

Neuropsychopharmacology • 14 Apr 2010 • Research

opioidalcoholdopaminebrain sciencegeneticstreatment

Read plain-English summary Open source

Genome-wide meta-analyses of cross substance use disorders in diverse populations

This article may help explain addiction science through research on opioid, alcohol, cannabis, nicotine. The source abstract begins by describing: “Substance use disorders (SUDs, including alcohol, cannabis, opioids, and tobacco) represent significant public health challenges.”

Key finding: Lastly, using a real-world dataset, we identified seven SUD-shared genes targeting drugs that may be repurposed for treating SUDs, particularly in those suffering from comorbid SUDs.

Molecular Psychiatry • 07 Oct 2025 • Research

opioidalcoholcannabisnicotinebrain sciencegenetics

Read plain-English summary Open source

Cannabidiol mitigates alcohol dependence and withdrawal with neuroprotective effects in the basolateral amygdala and striatum

This article may help explain addiction science through research on alcohol, cannabis, brain science, withdrawal. The source abstract begins by describing: “Alcohol use disorder (AUD) remains a pervasive public health issue with limited effective treatments.”

Key finding: These findings indicate that chronic CBD administration attenuates both behavioral and neurobiological facets of alcohol dependence by modulating neuronal excitability and preventing neurodegeneration, supporting its therapeutic potential for AUD and providing mechanistic insights for future research.

Neuropsychopharmacology • 10 Jul 2025 • Research

alcoholcannabisbrain sciencewithdrawalrelapsegenetics

Read plain-English summary Open source

Acetazolamide inhibition of carbonic anhydrase 4 reverses opioid-induced synaptic rearrangements in nucleus accumbens and reduces drug-seeking behavior

This article may help explain addiction science through research on opioid, cocaine, brain science, withdrawal. The source abstract begins by describing: “Persistent vulnerability to drug-seeking is driven by enduring synaptic adaptations, yet current μ-opioid receptor-targeting pharmacotherapies provide limited efficacy against these neuroadaptations.”

Key finding: By targeting a pathway independent of classical opioid receptor signaling, CA4 inhibition represents a mechanistically distinct strategy that may reduce relapse vulnerability in OUD.

Neuropsychopharmacology • 21 Jan 2026 • Research

opioidcocainebrain sciencewithdrawalrelapsetreatment

Read plain-English summary Open source

Medical and genetic correlates of long-term buprenorphine treatment in the electronic health records

This article may help explain addiction science through research on opioid, alcohol, cannabis, nicotine. The source abstract begins by describing: “Despite the benefits associated with longer buprenorphine treatment duration (i.e., >180 days) (BTD) for opioid use disorder (OUD), retention remains poor.”

Key finding: Longer BTD is associated with diagnoses of psychiatric and somatic conditions in the EHR, as is the genetic score for OUD, loneliness, problematic alcohol use, and externalizing disorders.

Translational Psychiatry • 10 Jan 2024 • Research

opioidalcoholcannabisnicotinegeneticsmental health

Read plain-English summary Open source